GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Angelalign Technology Inc (HKSE:06699) » Definitions » ROA %

Angelalign Technology (HKSE:06699) ROA % : 0.90% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Angelalign Technology ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Angelalign Technology's annualized Net Income for the quarter that ended in Dec. 2023 was HK$46 Mil. Angelalign Technology's average Total Assets over the quarter that ended in Dec. 2023 was HK$5,166 Mil. Therefore, Angelalign Technology's annualized ROA % for the quarter that ended in Dec. 2023 was 0.90%.

The historical rank and industry rank for Angelalign Technology's ROA % or its related term are showing as below:

HKSE:06699' s ROA % Range Over the Past 10 Years
Min: 1.14   Med: 10.54   Max: 14.99
Current: 1.14

During the past 6 years, Angelalign Technology's highest ROA % was 14.99%. The lowest was 1.14%. And the median was 10.54%.

HKSE:06699's ROA % is ranked better than
57.27% of 866 companies
in the Medical Devices & Instruments industry
Industry Median: -2.11 vs HKSE:06699: 1.14

Angelalign Technology ROA % Historical Data

The historical data trend for Angelalign Technology's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Angelalign Technology ROA % Chart

Angelalign Technology Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROA %
Get a 7-Day Free Trial 10.31 14.99 10.76 4.74 1.15

Angelalign Technology Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.93 3.47 6.25 1.39 0.90

Competitive Comparison of Angelalign Technology's ROA %

For the Medical Instruments & Supplies subindustry, Angelalign Technology's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Angelalign Technology's ROA % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Angelalign Technology's ROA % distribution charts can be found below:

* The bar in red indicates where Angelalign Technology's ROA % falls into.



Angelalign Technology ROA % Calculation

Angelalign Technology's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=58.49/( (5009.816+5202.728)/ 2 )
=58.49/5106.272
=1.15 %

Angelalign Technology's annualized ROA % for the quarter that ended in Dec. 2023 is calculated as:

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=46.304/( (5128.622+5202.728)/ 2 )
=46.304/5165.675
=0.90 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Dec. 2023) net income data. ROA % is displayed in the 30-year financial page.


Angelalign Technology  (HKSE:06699) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Dec. 2023 )
=Net Income/Total Assets
=46.304/5165.675
=(Net Income / Revenue)*(Revenue / Total Assets)
=(46.304 / 1880.5)*(1880.5 / 5165.675)
=Net Margin %*Asset Turnover
=2.46 %*0.364
=0.90 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) net income data. The Revenue data used here is two times the semi-annual (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Angelalign Technology ROA % Related Terms

Thank you for viewing the detailed overview of Angelalign Technology's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Angelalign Technology (HKSE:06699) Business Description

Traded in Other Exchanges
Address
No. 500 Zhengli Road, 6th Floor - 7th Floor, Building No. 7, KIC Business Center, Yangpu District, Shanghai, CHN
Angelalign Technology Inc is an investment holding company. It is principally engaged in clear aligner treatment solutions including treatment planning services, manufacturing, and marketing of clear aligners. The company provides dental professionals with self-developed digital orthodontics solutions. The company's Angelalign clear aligner system facilitates dental professionals throughout the entire clear aligner treatment process, including digitally-assisted case assessment support and treatment planning services, provide dental professionals with digitally-assisted case assessment support and treatment planning services, and helps dental professionals design, review and modify treatment plans.
Executives
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Morgan Stanley 2201 Interest of corporation controlled by you
Carecapital Ea, Inc 2201 Interest of corporation controlled by you
Carecapital Management Group Llc 2201 Interest of corporation controlled by you
Carecapital Moonstone Holdings Limited 2201 Interest of corporation controlled by you
Carecapital Dental Holdings Limited 2201 Interest of corporation controlled by you
Feng Dai 2201 Interest of corporation controlled by you
Shore Lead Limited 2201 Interest of corporation controlled by you
Sky Honour Enterprises Limited 2101 Beneficial owner
Li Huamin 2307 Founder of a discretionary trust who can infl
Carecapital Orthotech Limited 2101 Beneficial owner
Chen Kai 2201 Interest of corporation controlled by you
Jovial Day Global Limited 2201 Interest of corporation controlled by you
Vast Luck Global Limited 2101 Beneficial owner
Xing Zheng Quan Qiu Ji Jin Guan Li You Xian Gong Si 2102 Investment manager

Angelalign Technology (HKSE:06699) Headlines

No Headlines